We are pleased to be participating in the Food and Drug Law Institute (FDLI) Annual Conference, taking place May 2-3, 2019 in Washington, DC. This two-day event provides in-depth discussions and analyses on a wide variety of timely topics by bringing together experts from the federal government, industry, the private bar, non-profits, patient and consumer advocates, consulting organizations and academia.
Partner Marisol Mork will participate in a panel discussion, “Food and Dietary Supplement Class Action Litigation: Developments and Strategies” on Thursday, May 3, 2019 from 3:50 to 4:50 p.m. The session will explore litigation developments and procedural strategies to protect clients in class action suits.
Conference highlights include:
Keynote Address by Norman E. Sharpless, Acting Commissioner of Food and Drugs, FDA
Presentation of the FDA’s 2019 strategic priorities directly from the FDA Commissioner, Chief Counsel, Center Directors and other key leaders within the agency
Nearly 30 breakout sessions covering the latest in legal, regulatory, compliance, policy, marketing and related issues